MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mindwalk Holdings Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.640 Good morning, ladies and gentlemen, and thank you for joining us today for MindWalk's 00:00:05.640 -- 00:00:10.707 first quarter fiscal 2026 earnings call. We appreciate your 00:00:10.707 -- 00:00:16.115 time and interest in MindWalk, formerly Immunoprecise Antibodies. 00:00:16.115 -- 00:00:21.123 Today's call will be led by our CEO, Dr. Jennifer Bath, 00:00:21.123 -- 00:00:26.204 and interim CFO, Joe Scheffler. They will provide 00:00:26.204 -- 00:00:31.332 review of our financial performance, strategic initiatives, and key 00:00:31.332 -- 00:00:34.917 operational highlights for the first quarter. 00:00:34.917 -- 00:00:39.985 Please note that a copy of today's presentation along with our final 00:00:39.985 -- 00:00:46.134 financial statements will be available on our company's website for your reference. 00:00:46.134 -- 00:00:51.702 Before we begin, I'd like to remind everyone that today's discussion will include forward-looking 00:00:51.702 -- 00:00:56.842 statements. These are based on current expectations and assumptions 00:00:56.842 -- 00:01:02.670 and are subject to risks and uncertainties that could cause actual 00:01:02.670 -- 00:01:08.499 results to differ materially. Factors include, but are not limited to, global 00:01:08.499 -- 00:01:11.463 political and economic conditions, 00:01:11.463 -- 00:01:16.370 changes in the market dynamics, and other business risks. 00:01:16.370 -- 00:01:21.818 Unless otherwise noted, all financial figures discussed today are in Canadian dollars 00:01:21.818 -- 00:01:27.033 and These statements are made as of today, and we undertake no 00:01:27.033 -- 00:01:31.839 obligation to update them except as required by law. 00:01:31.839 -- 00:01:36.926 For a more detailed discussion of risks and unce...